Clinical Trials Browser

Erythema × Clear all

NCT02411656 2026-01-23

Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

Phase 2 Active not recruiting

71 enrolled 11 charts

Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03363763 2025-12-01

Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex

Phase 2 Terminated

24 enrolled 11 charts

Erythema, Exanthema, Fibroma, Tuberous Sclerosis, Facies

NCT02876107 2025-10-10

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

Phase 2 Active not recruiting

Breast Neoplasms, Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07021495 2025-08-19

SKINERGY

Abscess, Chronic Urticaria, Angioedema, Dermatitis, Atopic, Eczema, Erythema, Exanthema, Mycosis Fungoides, Neoplasms, Photosensitivity Disorders, Pruritus, Psoriasis, Urticaria, Hidradenitis Suppurativa, Plaque, Amyloid

NCT03344796 2023-07-27

UV Exposure Assessed With Wearable Sensor and Sun Protection

Phase NA Completed

164 enrolled 15 charts

Erythema, Skin Neoplasms, Sunburn

NCT01597921 2012-08-09

A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer

Breast Neoplasms, Erythema, Radiodermatitis